...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The Canadian journal of hospital pharmacy. >Standards of Clinical Practice for Renal Pharmacists
【24h】

Standards of Clinical Practice for Renal Pharmacists

机译：肾脏药师临床实践标准

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The prevalence of chronic kidney disease (CKD) continues to increase. Patients with stage 1 to 5 CKD and those undergoing dialysis are at extremely high risk for drug therapy problems (DTPs). In controlled trials involving general patient populations, clinical pharmacist interventions have reduced hospital admissions, length of hospital stay, readmis-sions, and emergency department visits. The activities of pharmacists most strongly associated with improved patient outcomes include participating on rounds, interviewing patients, performing medication reconciliation, counselling patients on discharge, and conducting postdischarge follow-up. A systematic review of 8 controlled trials involving patients with CKD showed that clinical pharmacist interventions improved management of anemia, blood pressure, and lipids, as well as calcium and phosphate parameters. In this patient population, clinical pharmacists' interventions reduced hospital admissions, length of hospital stay, and incidence of end-stage renal disease or death.
机译：慢性肾脏病（CKD）的患病率持续上升。患有1至5期CKD的患者以及接受透析的患者极有可能出现药物治疗问题（DTP）。在涉及普通患者人群的对照试验中，临床药剂师的干预措施减少了住院人数，住院时间，重新准备和急诊就诊。与改善患者预后最密切相关的药剂师活动包括参加巡回，采访患者，进行药物调和，为出院患者提供咨询以及进行出院后随访。对涉及CKD患者的8项对照试验的系统评价显示，临床药剂师的干预措施可改善贫血，血压，血脂以及钙和磷酸盐参数的管理。在该患者人群中，临床药剂师的干预减少了住院人数，住院时间以及终末期肾脏疾病或死亡的发生率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号